| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2017 | Consolidative CD8(+) Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation | Spinner, M. A.; Muffly, L. S.; Arai, S.; Johnston, L.; Meyer, E. H.; Miklos, D. B.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Strober, S.; Lowsky, R. | Blood | | | |
| 2015 | Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms | Narayan, R.; Benjamin, J.; Laport, G.; Tian, L.; Tate, K.; Elder, L.; Galvez, L.; Armstrong, R.; Sheehan, K.; Lowsky, R.; Arai, S.; Johnston, L.; Miklos, D.; Muffly, L. S.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Strober, S.; Negrin, R.; Meyer, E. | Blood | | | |
| 2018 | Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell Lymphoma | Spiegel, J. Y.; Sahaf, B.; Hossain, N.; Frank, M. J.; Claire, G.; Abramian, M.; Latchford, T.; Villa, B.; Cancilla, J.; Oak, J.; Natkunam, Y.; Long, S. R.; Arai, S.; Johnston, L. J.; Lowsky, R.; Meyer, E. H.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Kong, K. A.; Mackall, C. L.; Miklos, D. B. | Blood | | | |
| 2017 | HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity | Spinner, M. A.; Fernandez-Vina, M.; Creary, L. E.; Quinn, O.; Elder, L.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Shizuru, J. A.; Wen-Kai Weng ; Laport, G. G.; Strober, S.; Lowsky, R.; Rezvani, A. R. | Blood Advances | | | |
| 2016 | Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myeloma | Neppalli, A. K.; Shizuru, J.; Johnston, L. J.; Muffly, L. S.; Wen-Kai Weng ; Negrin, R.; Meyer, E.; Laport, G.; Lowsky, R.; Arai, S.; Miklos, D. B.; Rezvani, A. R. | Journal of Clinical Oncology | | | |
| 2018 | Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort | Spinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Elder, L. V.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R. | Blood | | | |
| 2019 | Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort | Spinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R. | Blood Advances | | | |
| - | Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma | Lemieux, C.; Muffly, L. S.; Rezvani, A.; Lowsky, R.; Iberri, D. J.; Craig, J. K.; Frank, M. J.; Johnston, L. J.; Liedtke, M.; Negrin, R.; Wen-Kai Weng ; Meyer, E.; Shizuru, J.; Shiraz, P.; Arai, S.; Miklos, D. B.; Sidana, S. | Bone Marrow Transplantation | | | |
| 2016 | Phase I Study of CD8 Memory T-Cell Donor Lymphocyte Infusion for Relapse of Hematologic Malignancies Following Matched Related Donor Allogeneic Hematopoietic Cell Transplantation | Muffly, L. S.; Sheehan, K.; Armstrong, R.; Tate, K.; Tudisco, C.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | | | |
| 2016 | Validation of the hematopoietic cell transplantation-specific comorbidity index in non-myeloablative allogeneic stem cell transplantation | Veeraputhiran, M.; Arai, S.; Lowsky, R.; Miklos, D. B.; Meyer, E.; Muffly, L. S.; Negrin, R.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Johnston, L. J. | Journal of Clinical Oncology | | | |
